PROVECTUS BIOPHARMACEUTICALS, INC. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PROVECTUS BIOPHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PROVECTUS BIOPHARMACEUTICALS, INC. for March 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 0.85 | 133,333 | 113,333 | 133,333 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 1.00 | 133,333 | 133,333 | 0 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 0.85 | 133,333 | 113,333 | 133,333 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 1.00 | 133,333 | 133,333 | 0 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 106,000 | 106,000 | 296,503 | 190.5 K to 296.5 K (+55.64 %) |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 27,333 | 27,333 | 1,411,829 | 1.4 M to 1.4 M (+1.97 %) |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 133,333 | 133,333 | 1,384,496 | 1.3 M to 1.4 M (+10.66 %) |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | O | 0.85 | 306,947 | 260,905 | 306,947 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | O | 1.00 | 306,947 | 306,947 | 359,719 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | O | 1.00 | 106,000 | 106,000 | 930,248 | 824.2 K to 930.2 K (+12.86 %) |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | O | 1.00 | 200,947 | 200,947 | 5,714,183 | 5.5 M to 5.7 M (+3.64 %) |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | O | 0.85 | 100,000 | 85,000 | 100,000 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | O | 1.25 | 100,000 | 125,000 | 0 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | O | 0.85 | 100,000 | 85,000 | 100,000 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | O | 1.25 | 100,000 | 125,000 | 0 | |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Buy | O | 1.25 | 100,000 | 125,000 | 786,300 | 686.3 K to 786.3 K (+14.57 %) |
| Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Buy | O | 1.25 | 100,000 | 125,000 | 686,300 | 586.3 K to 686.3 K (+17.06 %) |